These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11772415)

  • 1. Lipid lowering in acute coronary syndromes: new evidence, new questions.
    Schwartz GG; Olsson AG
    Curr Atheroscler Rep; 2002 Jan; 4(1):1-3. PubMed ID: 11772415
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary coronary heart disease prevention. Will CEPT inhibitors be the next breakthrough?].
    Einecke D
    MMW Fortschr Med; 2011 Dec; 153(49-50):17-8. PubMed ID: 22308584
    [No Abstract]   [Full Text] [Related]  

  • 3. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comment from tHE cardiologic-angiologic viewpoint].
    Rosemann A
    Praxis (Bern 1994); 2011 Jul; 100(14):857-8. PubMed ID: 21732298
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive cholesterol lowering: no longer a myth.
    Bitzur R; Harats D
    Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708
    [No Abstract]   [Full Text] [Related]  

  • 7. Don't trust an LDL over 70?
    Aronow WS
    Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel approaches to lipid lowering: what is on the horizon?
    Brown WV
    Am J Cardiol; 2001 Mar; 87(5A):23B-27B. PubMed ID: 11256846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of statins in acute coronary syndromes.
    Foody JM; Nissen SE
    Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cholesterol-lowering treatment.
    Law M; Wald NJ
    Lancet; 2006 Feb; 367(9509):469-70; author reply 470-1. PubMed ID: 16473115
    [No Abstract]   [Full Text] [Related]  

  • 12. Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting.
    Gotto AM; Grundy SM
    Circulation; 1999 Mar; 99(8):E1-7. PubMed ID: 10051310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).
    Boccuzzi SJ; Weintraub WS; Kosinski AS; Roehm JB; Klein JL
    Am J Cardiol; 1998 Mar; 81(5):632-6. PubMed ID: 9514463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atorvastatin].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of atorvastatin in cholesterol lowering.
    Farmer JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):94-5. PubMed ID: 12573192
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of recent large cholesterol-lowering trials and implications for clinical management.
    Gotto AM
    Am J Cardiol; 1997 Jun; 79(12):1663-6. PubMed ID: 9202359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hydroxymethylglutaryl coenzyme A reductase inhibitors].
    Schuff-Werner P
    Internist (Berl); 1994 Mar; 35(3):288-94; discussion 295. PubMed ID: 8175295
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.